Indefinite Delivery Contract HHSN261201000076I

Award Date 9/8/10
Last Date to Order 9/30/14
Ultimate Awardee
Not listed
Pricing Type
Firm Fixed Price
Legislative Mandate
Not listed
National Interest Action
None
Award Type
Multiple
Primary Consortia Member
Not listed
Similar IDVs
This Indefinite Delivery Contract (IDC) was awarded by the National Cancer Institute (NCI), a civilian agency, to the British Columbia Cancer Agency Branch, a Canadian non-profit organization, to procure tissue samples and data from various cancer types to support the NCI's Cancer Genome Atlas (TCGA) program. The $16,000 firm fixed-price delivery order was issued on September 20, 2010 under the NCI Cancer Genome Atlas Program Tissue Purchase contract, which does not have a set-aside designation....
This indefinite delivery contract was awarded by the National Cancer Institute (NCI), a civilian agency within the U.S. Department of Health and Human Services, to the Sloan-Kettering Institute for Cancer Research, a non-profit organization. The contract, valued at $236,000.00, is part of the NCI Cancer Genome Atlas (TCGA) Program and aims to procure tissue samples and data from various cancer types for the TCGA's comprehensive genomic characterization efforts. The contract was awarded in August...
This indefinite delivery contract was awarded by the National Cancer Institute (NCI), a component of the U.S. Department of Health and Human Services, to the Sloan-Kettering Institute for Cancer Research, a non-profit organization located in New York, NY. The contract, valued at $200,000, supports the NCI's Cancer Genome Atlas (TCGA) program, which aims to collect and analyze tissue samples and data from various cancer types. The initial $120,500 task order under this contract requires the...
This indefinite delivery contract (IDC) was awarded by the National Cancer Institute (NCI), a civilian agency, to The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc. (HJF), a non-profit organization. The $301,548 contract, with no set-aside designation, is for the recovery and procurement of tissue samples and data from various types of cancer to support the Cancer Genome Atlas (TCGA) program, which is funded by the American Recovery and Reinvestment Act (ARRA). The...
This federal contract IDV was awarded by the National Cancer Institute (NCI), a component of the U.S. Department of Health and Human Services, to the Sloan-Kettering Institute for Cancer Research. The contract, with a ceiling value of $103,516.60, provides for the acquisition of tissue samples and associated data from various cancer types to support the NCI's Cancer Genome Atlas (TCGA) program, which aims to comprehensively characterize the genomic changes in major cancer types. The contract was...
This indefinite delivery contract was awarded by the National Cancer Institute (NCI), a civilian agency, to the Sloan-Kettering Institute for Cancer Research, a non-profit organization. The $550,000 single-award contract is part of the NCI Cancer Genome Atlas Program Tissue Purchase master contract and aims to procure tissue samples and data from various types of cancer for the Cancer Genome Atlas (TCGA) program. Under a $488,000 delivery order, Sloan-Kettering Institute for Cancer Research, a...
This Indefinite Delivery Contract (IDC) was awarded by the National Cancer Institute (NCI), a civilian agency, to Wielkopolskie Centrum Onkologii IM Marii Sklodowskiej Curie, also known as Centrum Onkologii, to provide tissue samples and data from various types of cancer for the Cancer Genome Atlas (TCGA) program. The contract, valued at $420,000, is a firm fixed price award and is not set aside for any special designation. It was issued under the NCI Cancer Genome Atlas Program Tissue...
This indefinite delivery contract (IDC) was awarded by the National Cancer Institute (NCI), a civilian federal agency under the Department of Health and Human Services, to the Ontario Institute for Cancer Research (OICR), a non-profit research organization. The contract supports the NCI's Cancer Genome Atlas (TCGA) program, which aims to collect and analyze tissue samples and data from various cancer types. The contract has a total ceiling value of $784,000 and a period of performance from...
This indefinite delivery contract was awarded by the National Cancer Institute (NCI), a civilian agency within the U.S. Department of Health and Human Services, to Indivumed, Inc. to provide tissue samples and data from various types of cancer for the Cancer Genome Atlas (TCGA) program. The contract has a total ceiling value of $2,712,155.00 and does not have a set-aside designation. The contract consists of three firm-fixed-price delivery orders with a combined total value of $2,259,118.07. The...
This federal contract IDV was awarded by the National Cancer Institute (NCI), a civilian agency under the Department of Health and Human Services, to support the Cancer Genome Atlas (TCGA) program. The fixed-price, $263,765.60 contract was awarded to the University Health Network (UHN), a non-profit academic health sciences center in Canada, to provide tissue samples and data from various types of cancer for the TCGA program. The contract supports the American Recovery and Reinvestment Act...

This federal contract IDV was awarded by the National Cancer Institute (NCI), a civilian agency within the U.S. Department of Health and Human Services (HHS), to Fundacio De Recerca Clinic Barcelona-Institut D'investigacions Biomediques August Pi I Sunyer, a non-profit organization and foundation focused on biomedical research. The $6,000 Firm Fixed Price delivery order contract supports the collection of tissue samples and data from various types of cancer for the Cancer Genome Atlas (TCGA) program, which is part of the NCI's efforts to advance cancer research. The contract is a delivery order under the NCI Cancer Genome Atlas Program Tissue Purchase master IDIQ contract vehicle and does not have a set-aside designation. The period of performance runs through September 30, 2013, with the place of performance located in Spain.

The purpose of this contract is to provide tissue samples and data from various cancer types to support the TCGA program, a collaborative, multi-institutional effort to generate comprehensive, multi-dimensional maps of the key genomic changes in major types and subtypes of cancer. This information is critical for improving the ability to diagnose, treat, and prevent cancer. Through this contract, the non-profit organization Fundacio De Recerca Clinic Barcelona-Institut D'investigacions Biomediques August Pi I Sunyer will deliver these essential research resources to advance the NCI's cancer genomics initiative.

Generated 4/2/25, 9:54 AM